AU2003277215A8 - Novel neurokinin antagonists and methods of use thereof - Google Patents
Novel neurokinin antagonists and methods of use thereofInfo
- Publication number
- AU2003277215A8 AU2003277215A8 AU2003277215A AU2003277215A AU2003277215A8 AU 2003277215 A8 AU2003277215 A8 AU 2003277215A8 AU 2003277215 A AU2003277215 A AU 2003277215A AU 2003277215 A AU2003277215 A AU 2003277215A AU 2003277215 A8 AU2003277215 A8 AU 2003277215A8
- Authority
- AU
- Australia
- Prior art keywords
- methods
- neurokinin antagonists
- novel neurokinin
- novel
- antagonists
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/04—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41504502P | 2002-10-01 | 2002-10-01 | |
| US60/415,045 | 2002-10-01 | ||
| US42518702P | 2002-11-08 | 2002-11-08 | |
| US42518602P | 2002-11-08 | 2002-11-08 | |
| US42513002P | 2002-11-08 | 2002-11-08 | |
| US60/425,130 | 2002-11-08 | ||
| US60/425,187 | 2002-11-08 | ||
| US60/425,186 | 2002-11-08 | ||
| PCT/US2003/031153 WO2004030629A2 (en) | 2002-10-01 | 2003-09-30 | Novel neurokinin antagonists and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003277215A1 AU2003277215A1 (en) | 2004-04-23 |
| AU2003277215A8 true AU2003277215A8 (en) | 2004-04-23 |
Family
ID=32074647
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003277215A Abandoned AU2003277215A1 (en) | 2002-10-01 | 2003-09-30 | Novel neurokinin antagonists and methods of use thereof |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003277215A1 (en) |
| WO (1) | WO2004030629A2 (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7612078B2 (en) | 2003-03-31 | 2009-11-03 | Epix Delaware, Inc. | Piperidinylamino-thieno[2,3-D] pyrimidine compounds |
| US7488736B2 (en) | 2004-05-17 | 2009-02-10 | Epix Delaware, Inc. | Thienopyridinone compounds and methods of treatment |
| US7576211B2 (en) | 2004-09-30 | 2009-08-18 | Epix Delaware, Inc. | Synthesis of thienopyridinone compounds and related intermediates |
| US7598265B2 (en) | 2004-09-30 | 2009-10-06 | Epix Delaware, Inc. | Compositions and methods for treating CNS disorders |
| US7407966B2 (en) | 2004-10-07 | 2008-08-05 | Epix Delaware, Inc. | Thienopyridinone compounds and methods of treatment |
| DE102004055998A1 (en) * | 2004-11-19 | 2006-05-24 | Rheinische Friedrich-Wilhelms-Universität Bonn | Low molecular weight inhibitors of guanine nucleotide exchange factors of the cytohesin family |
| BRPI0907122B8 (en) | 2008-01-11 | 2021-05-25 | Albany Molecular Res Inc | substituted pyridoindoles (1-azinone) compounds, pharmaceutical composition comprising said compounds, and uses thereof |
| EP2445877B1 (en) | 2008-12-03 | 2014-07-23 | Nanotherapeutics, Inc. | Bicyclic compounds and methods of making and using same |
| WO2011003021A1 (en) | 2009-07-01 | 2011-01-06 | Albany Molecular Research, Inc. | Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof |
| WO2011003007A1 (en) | 2009-07-01 | 2011-01-06 | Albany Molecular Research, Inc. | Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof |
| JP2012532144A (en) | 2009-07-01 | 2012-12-13 | アルバニー モレキュラー リサーチ， インコーポレイテッド | Azinone-substituted azepino [B] indoles and pyrido-pyrrolo-azepine MCH-1 antagonists and methods for making and using the same |
| WO2011003012A1 (en) | 2009-07-01 | 2011-01-06 | Albany Molecular Research, Inc. | Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof |
| US8993765B2 (en) | 2010-12-21 | 2015-03-31 | Albany Molecular Research, Inc. | Tetrahydro-azacarboline MCH-1 antagonists, methods of making, and uses thereof |
| WO2012088038A2 (en) | 2010-12-21 | 2012-06-28 | Albany Molecular Research, Inc. | Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof |
| WO2018130123A1 (en) * | 2017-01-11 | 2018-07-19 | 南京圣和药业股份有限公司 | Pentacyclic compound as selective estrogen receptor down-regulator and use thereof |
| EP3710003A4 (en) * | 2017-09-08 | 2022-03-02 | Symberix, Inc. | COMPOUNDS, COMPOSITIONS, AND METHODS FOR SELECTIVELY INHIBITING Beta- -GLUCURONIDASES AND ALLEVIATING SIDE EFFECTS ASSOCIATED WITH DRUG TREATMENT INDUCED DIARRHEA |
-
2003
- 2003-09-30 AU AU2003277215A patent/AU2003277215A1/en not_active Abandoned
- 2003-09-30 WO PCT/US2003/031153 patent/WO2004030629A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004030629A2 (en) | 2004-04-15 |
| WO2004030629A3 (en) | 2004-11-04 |
| AU2003277215A1 (en) | 2004-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1079789A1 (en) | Vasculostatic agents and methods of use thereof | |
| HK1087703A1 (en) | Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists | |
| AU2003217870A8 (en) | Pini-modulating compounds and methods of use thereof | |
| AU2003213673A8 (en) | Pin1-modulating compounds and methods of use thereof | |
| EP1608318A4 (en) | Cxcr4 antagonists and methods of their use | |
| AU2003259735A8 (en) | Small-mer compositions and methods of use | |
| AU2003303128A8 (en) | Inhibitors and methods of use thereof | |
| EP1545468A4 (en) | Sustained-release opioid formulations and methods of use | |
| AU2003299734A8 (en) | Luminescent polymers and methods of use thereof | |
| EP1507756A4 (en) | Ccr9 inhibitors and methods of use thereof | |
| PL377861A1 (en) | Substituted amine derivatives and methods of use | |
| EP1465615A4 (en) | Tricyclic-bis-enone derivatives and methods of use thereof | |
| EP1551376A4 (en) | Immunomodulatory compositions, methods of making, and methods of use thereof | |
| IL164703A0 (en) | ImidazoÄ1,2-AÜpyrazin-8-ylamines method of making and method of use thereof | |
| PL374832A1 (en) | Novel substituted benzimidazole dosage forms and method of using same | |
| HK1060727A1 (en) | Antagonists of mcp-1 function and methods of use thereof | |
| AU2003288902A8 (en) | Microcapsules and methods of use | |
| HK1060728A1 (en) | Antagonists of mcp-1 function and methods of use thereof | |
| EP1497270A4 (en) | Amide compounds and methods of using the same | |
| EP1567515A4 (en) | Novel lapachone compounds and methods of use thereof | |
| AU2003277215A8 (en) | Novel neurokinin antagonists and methods of use thereof | |
| EP1476150A4 (en) | Carboxyfullerenes and methods of use thereof | |
| EP1638565A4 (en) | Substituted piperidine compounds and methods of their use | |
| EP1663255A4 (en) | Withanamide and withanolide compositions and method of use thereof | |
| AU2003275056A8 (en) | Novel lapacho compounds and methods of use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |